Invention Grant
- Patent Title: Compounds and methods for treating autoimmunity
-
Application No.: US16357397Application Date: 2019-03-19
-
Publication No.: US11052060B2Publication Date: 2021-07-06
- Inventor: Steve Orndorff , Aaron Michels
- Applicant: ImmunoMolecular Therapeutics, INC. , The Regents of the University of Colorado, a body corporate
- Applicant Address: US MA Woburn; US CO Denver
- Assignee: ImmunoMolecular Therapeutics, INC.,The Regents of the University of Colorado, a body corporate
- Current Assignee: ImmunoMolecular Therapeutics, INC.,The Regents of the University of Colorado, a body corporate
- Current Assignee Address: US MA Woburn; US CO Denver
- Agency: Sheridan Ross P.C.
- Main IPC: A61K31/216
- IPC: A61K31/216 ; A61K45/06 ; A61P37/00 ; A61P3/10 ; A61K31/198
Abstract:
Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.
Public/Granted literature
- US20190262301A1 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNITY Public/Granted day:2019-08-29
Information query
